Ani Pharmaceuticals (ANIP) Inventory (2012 - 2026)

Ani Pharmaceuticals has disclosed Inventory across 15 years of filings, most recently posting $143.1 million for Q2 2026.

• In Q2 2026, Inventory rose 3.49% year-over-year to $143.1 million; the TTM figure through Jun 2026 stood at $143.1 million (up 3.49% YoY), while the FY2025 annual figure was $143.1 million, up 4.59% from the prior year.
• Inventory came in at $143.1 million for Q2 2026 at Ani Pharmaceuticals, roughly flat from $143.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $148.0 million in Q3 2024 to a low of $90.4 million in Q1 2022.
• Average Inventory over 5 years is $122.4 million, with a median of $119.6 million recorded in 2024.
• Year-over-year, Inventory surged 57.44% in 2022 and declined 1.06% in 2025.
• Over 5 years, Inventory stood at $105.4 million in 2022, then gained by 5.54% to $111.2 million in 2023, then advanced by 23.01% to $136.8 million in 2024, then climbed by 4.59% to $143.1 million in 2025, then increased by 0.06% to $143.1 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $143.1 million in Q2 2026, $143.5 million in Q1 2026, and $143.1 million in Q4 2025.